Skip to main content
Erschienen in: Wiener klinische Wochenschrift 15-16/2013

01.08.2013 | original article

A new model using platelet indices to predict liver fibrosis in patients with chronic hepatitis B infection

verfasst von: Bahadir Ceylan, MD, Bilgül Mete, Muzaffer Fincanci, Turan Aslan, Yasemin Akkoyunlu, Nail Ozguneş, Onur Colak, Alper Gunduz, Ebubekir Senates, Resat Ozaras, Ayşe İnci, Fehmi Tabak

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 15-16/2013

Einloggen, um Zugang zu erhalten

Summary

Background

We aimed to investigate whether mean platelet volume (MPV) and platelet distribution width (PDW) are variables determining the severity of liver fibrosis in patients with chronic HBV infection.

Methods

Patients were divided into two groups with fibrosis scores of 0–2 and 3–6 (according to Ishac scoring system). Whether MPV and PDW were independent variables determining the severity of liver fibrosis score or not was investigated by comparing these groups.

Results

Of the 111 cases, 74 (66.7 %) were male (mean age 37.7 ± 11.6 years). Twenty-two of the cases (19.8 %) were HBeAg-positive. Fibrosis scores of 42 cases (37.8 %) were ≥ 3 and the remaining 69 cases had fibrosis scores < 3 (62.2 %). Independent variables determining the severity of fibrosis score were low levels of albumin and mean platelet volume, and high levels of prothrombin time and PDW (Odds ratio (95 % confidence interval) and p values were 0.105 (0.018–0.605) and 0.012 for albumin, 0.402 (0.234–0.692) and 0.001 for mean platelet volume, 1.529 (1.183–1.975) and 0.001 for PDW, and 0.924 (0.875–0.976) and 0.005 for prothrombin time, respectively). The sensitivity, specificity, positive predictive value and negative predictive value of regression model that is established using above mentioned parameters were 88.1, 75.3, 68.5, and 91.7 %, respectively (AUC = 0.886, p = 0.0001).

Conclusions

MPV and PDW are independent variables determining the severity of liver fibrosis, and the regression model that is established using these parameters along with other markers, may give more information about the severity of liver fibrosis.
Literatur
1.
Zurück zum Zitat Koda M, Matunaga Y, Kawakami M, Kishimoto Y, Suou T, Murawaki Y. FibroIndex, a practical index for predicting significant fibrosis in patients with chronic hepatitis C. Hepatology. 2007;45:297–306.PubMedCrossRef Koda M, Matunaga Y, Kawakami M, Kishimoto Y, Suou T, Murawaki Y. FibroIndex, a practical index for predicting significant fibrosis in patients with chronic hepatitis C. Hepatology. 2007;45:297–306.PubMedCrossRef
2.
Zurück zum Zitat Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology. 2006;43:1317–25.PubMedCrossRef Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology. 2006;43:1317–25.PubMedCrossRef
3.
Zurück zum Zitat Rossi E, Adams L, Prins A, Bulsara M, Boer B de, Garas G, et al. Validation of the FibroTest biochemical markers score in assessing liver fibrosis in hepatitis C patients. Clin Chem. 2003;49:450–4.PubMedCrossRef Rossi E, Adams L, Prins A, Bulsara M, Boer B de, Garas G, et al. Validation of the FibroTest biochemical markers score in assessing liver fibrosis in hepatitis C patients. Clin Chem. 2003;49:450–4.PubMedCrossRef
4.
Zurück zum Zitat Adams LA, Bulsara M, Rossi E, DeBoer B, Speers D, George J, et al. Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection. Clin Chem. 2005;51:1867–73.PubMedCrossRef Adams LA, Bulsara M, Rossi E, DeBoer B, Speers D, George J, et al. Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection. Clin Chem. 2005;51:1867–73.PubMedCrossRef
5.
Zurück zum Zitat Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003;38:518–26.PubMedCrossRef Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003;38:518–26.PubMedCrossRef
6.
Zurück zum Zitat Park GJ, Lin BP, Ngu MC, Jones DB, Katelaris PH. Aspartate aminotransferase: alanine aminotransferase ratio in chronic hepatitis C infection: is it a useful predictor of cirrhosis? J Gastroenterol Hepatol. 2000;15:386–90.PubMedCrossRef Park GJ, Lin BP, Ngu MC, Jones DB, Katelaris PH. Aspartate aminotransferase: alanine aminotransferase ratio in chronic hepatitis C infection: is it a useful predictor of cirrhosis? J Gastroenterol Hepatol. 2000;15:386–90.PubMedCrossRef
7.
Zurück zum Zitat Turhan O, Coban E, Inan D, Yalcin AN. Increased mean platelet volume in chronic hepatitis B patients with inactive disease. Med Sci Monit. 2010;16:202–5. Turhan O, Coban E, Inan D, Yalcin AN. Increased mean platelet volume in chronic hepatitis B patients with inactive disease. Med Sci Monit. 2010;16:202–5.
8.
Zurück zum Zitat Ekiz F, Yüksel O, Koçak E, Yιlmaz B, AltιnbaŠ A, Çoban Š, et al. Mean platelet volume as a fibrosis marker in patients with chronic hepatitis B. J Clin Lab Anal. 2011;25:162–5.PubMedCrossRef Ekiz F, Yüksel O, Koçak E, Yιlmaz B, AltιnbaŠ A, Çoban Š, et al. Mean platelet volume as a fibrosis marker in patients with chronic hepatitis B. J Clin Lab Anal. 2011;25:162–5.PubMedCrossRef
9.
Zurück zum Zitat Kaser A, Brandacher G, Steurer W, Kaser S, Offner FA, Zoller H, et al. Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis. Blood. 2001;98:2720–55.PubMedCrossRef Kaser A, Brandacher G, Steurer W, Kaser S, Offner FA, Zoller H, et al. Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis. Blood. 2001;98:2720–55.PubMedCrossRef
10.
Zurück zum Zitat Longo DL, Henry PH. Enlargement of lymph nodes and spleen (Chapter 60). Harrison’s principles of internal medicine. 17th Ed. New York: McGraw-Hill Companies; 2008. pp. 370–375. Longo DL, Henry PH. Enlargement of lymph nodes and spleen (Chapter 60). Harrison’s principles of internal medicine. 17th Ed. New York: McGraw-Hill Companies; 2008. pp. 370–375.
11.
Zurück zum Zitat Mohamadnejad M, Montazeri G, Fazlollahi A, Zamani F, Nasiri J, Nobakht H, et al. Noninvasive markers of liver fibrosis and inflammation in chronic hepatitis B virus related liver. Am J Gastroenterol. 2006;101:2537–45.PubMedCrossRef Mohamadnejad M, Montazeri G, Fazlollahi A, Zamani F, Nasiri J, Nobakht H, et al. Noninvasive markers of liver fibrosis and inflammation in chronic hepatitis B virus related liver. Am J Gastroenterol. 2006;101:2537–45.PubMedCrossRef
12.
Zurück zum Zitat Hui A, Chan HL, Wong VW, Liew CT, Chim AM, Chan FK, et al. Identification of chronic hepatitis B patients without significant liver fibrosis by a simple noninvasive predictive model. Am J Gastroenterol. 2005;100:616–23.PubMedCrossRef Hui A, Chan HL, Wong VW, Liew CT, Chim AM, Chan FK, et al. Identification of chronic hepatitis B patients without significant liver fibrosis by a simple noninvasive predictive model. Am J Gastroenterol. 2005;100:616–23.PubMedCrossRef
13.
Zurück zum Zitat Zeng MD, Lu LG, Mao YM, Qiu DK, Li JQ, Wan MB, et al. Prediction of significant fibrosis in HBeAg-positive patients with chronic hepatitis B by a noninvasive model. Hepatology. 2005;42:1437–45.PubMedCrossRef Zeng MD, Lu LG, Mao YM, Qiu DK, Li JQ, Wan MB, et al. Prediction of significant fibrosis in HBeAg-positive patients with chronic hepatitis B by a noninvasive model. Hepatology. 2005;42:1437–45.PubMedCrossRef
14.
Zurück zum Zitat Pan JJ, Yang CF, Chu CJ, Chang FY, Lee SD. Prediction of liver fibrosis in patients with chronic hepatitis B by serum markers. Hepatogastroenterology. 2007;54:1503–6.PubMed Pan JJ, Yang CF, Chu CJ, Chang FY, Lee SD. Prediction of liver fibrosis in patients with chronic hepatitis B by serum markers. Hepatogastroenterology. 2007;54:1503–6.PubMed
15.
Zurück zum Zitat Schmilovitz-Weiss H, Tovar A, Halpern M, Sulkes J, Braun M, Rotman Y, et al. Predictive value of serum globulin levels for the extent of hepatic fibrosis in patients with chronic hepatitis B infection. J Viral Hepat. 2006;13:671–7.PubMedCrossRef Schmilovitz-Weiss H, Tovar A, Halpern M, Sulkes J, Braun M, Rotman Y, et al. Predictive value of serum globulin levels for the extent of hepatic fibrosis in patients with chronic hepatitis B infection. J Viral Hepat. 2006;13:671–7.PubMedCrossRef
16.
Zurück zum Zitat Wai C-T, Cheng CL, Wee A, Dan Y-Y, Chan E, Chua W, et al. Noninvasive models for predicting histology in patients with chronic hepatitis B. Liver Int. 2006;26:666–72.PubMedCrossRef Wai C-T, Cheng CL, Wee A, Dan Y-Y, Chan E, Chua W, et al. Noninvasive models for predicting histology in patients with chronic hepatitis B. Liver Int. 2006;26:666–72.PubMedCrossRef
17.
Zurück zum Zitat Liu WP, Xu DJ, Zhao LR, Lu ZH, Wang YH, Lang ZW, et al. The prediction and validation of liver fibrosis by a noninvasive model and validation in patients with chronic hepatitis B. Zhonghua Nei Ke Za Zhi. 2008;47:308–12.PubMed Liu WP, Xu DJ, Zhao LR, Lu ZH, Wang YH, Lang ZW, et al. The prediction and validation of liver fibrosis by a noninvasive model and validation in patients with chronic hepatitis B. Zhonghua Nei Ke Za Zhi. 2008;47:308–12.PubMed
18.
Zurück zum Zitat Vardar R, Gunsar F, Sertoz R, Ozacar T, Nart D, Barbet FY, et al. Hepatogastroenterology. 2010;57:908–12. Vardar R, Gunsar F, Sertoz R, Ozacar T, Nart D, Barbet FY, et al. Hepatogastroenterology. 2010;57:908–12.
19.
Zurück zum Zitat Kim BK, Kim SA, Park YN, Cheong JY, Kim HS, Park JY, et al. Noninvasive models to predict liver cirrhosis in patients with chronic hepatitis B. Liver Int. 2007;27:969–76.PubMedCrossRef Kim BK, Kim SA, Park YN, Cheong JY, Kim HS, Park JY, et al. Noninvasive models to predict liver cirrhosis in patients with chronic hepatitis B. Liver Int. 2007;27:969–76.PubMedCrossRef
20.
Zurück zum Zitat Chen YP, Hou JL, Dai L, Wang JL, Zhu YF. Ultrasonografic scores combined with blood indexes for screening and predicting compensated liver cirrhosis in chronic hepatitis B patients. Nan Fang Yi Ke Da Xue Bao. 2008;28:2157–60. Chen YP, Hou JL, Dai L, Wang JL, Zhu YF. Ultrasonografic scores combined with blood indexes for screening and predicting compensated liver cirrhosis in chronic hepatitis B patients. Nan Fang Yi Ke Da Xue Bao. 2008;28:2157–60.
21.
Zurück zum Zitat Zhou K, Gao CF, Zhao YP, Liu HL, Zheng RD, Xian JC, et al. Simpler score of routine laboratory tests predicts liver fibrosis in patients with chronic hepatitis B. J Gastroenterol Hepatol. 2010;25:1569–77.PubMedCrossRef Zhou K, Gao CF, Zhao YP, Liu HL, Zheng RD, Xian JC, et al. Simpler score of routine laboratory tests predicts liver fibrosis in patients with chronic hepatitis B. J Gastroenterol Hepatol. 2010;25:1569–77.PubMedCrossRef
22.
Zurück zum Zitat Imperial JC. Natural history of chronic hepatitis B and C. J Gastroenterol Hepatol. 1999;14:1–5.CrossRef Imperial JC. Natural history of chronic hepatitis B and C. J Gastroenterol Hepatol. 1999;14:1–5.CrossRef
23.
Zurück zum Zitat Poynard T, Mathurin P, Lai CL, Guyader D, Poupon R, Tainturier MH, et al. A comparison of fibrosis progression in chronic liver diseases. J Hepatol. 2003;38:257–65.PubMedCrossRef Poynard T, Mathurin P, Lai CL, Guyader D, Poupon R, Tainturier MH, et al. A comparison of fibrosis progression in chronic liver diseases. J Hepatol. 2003;38:257–65.PubMedCrossRef
24.
Zurück zum Zitat Aster R. Pooling of platelets in the spleen: role in the pathogenesis “hypersplenic” thrombocytopenia. J Clin Invest. 1996;45:645–57.CrossRef Aster R. Pooling of platelets in the spleen: role in the pathogenesis “hypersplenic” thrombocytopenia. J Clin Invest. 1996;45:645–57.CrossRef
25.
Zurück zum Zitat Kawasaki T, Takeshita A, Souda K, Kobayashi Y, Kikuyama M, Suzuki F, et al. Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis. Am J Gastroenterol. 1999;94:1918–22.PubMedCrossRef Kawasaki T, Takeshita A, Souda K, Kobayashi Y, Kikuyama M, Suzuki F, et al. Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis. Am J Gastroenterol. 1999;94:1918–22.PubMedCrossRef
26.
Zurück zum Zitat Kondo R, Yano H, Nakashima O, Tanikawa K, Nomura Y, Kage M. Accumulation of platelets in the liver may be an important contributory factor to thrombocytopenia and liver fibrosis in chronic hepatitis C. J Gastroenterol. 2013;48:526–34. doi:10.1007/s00535-012-0656-2.PubMedCrossRef Kondo R, Yano H, Nakashima O, Tanikawa K, Nomura Y, Kage M. Accumulation of platelets in the liver may be an important contributory factor to thrombocytopenia and liver fibrosis in chronic hepatitis C. J Gastroenterol. 2013;48:526–34. doi:10.1007/s00535-012-0656-2.PubMedCrossRef
27.
Zurück zum Zitat Purnak T, Olmez S, Torun S, Efe C, Sayilir A, Ozaslan E,et al. Mean platelet volume is increased in chronic hepatitis C patients with advanced fibrosis. Clin Res Hepatol Gastroenterol. 2013;37:41–6. doi:10.1016/j.clinre.2012.03035.PubMedCrossRef Purnak T, Olmez S, Torun S, Efe C, Sayilir A, Ozaslan E,et al. Mean platelet volume is increased in chronic hepatitis C patients with advanced fibrosis. Clin Res Hepatol Gastroenterol. 2013;37:41–6. doi:10.1016/j.clinre.2012.03035.PubMedCrossRef
28.
Zurück zum Zitat Gasparyan AY, Ayvazyan L, Mikhailidis DP, Kitas GD. Mean platelet volume: a link between thrombosis and inflammation? Curr Pharm Des. 2011;17:47–58.PubMedCrossRef Gasparyan AY, Ayvazyan L, Mikhailidis DP, Kitas GD. Mean platelet volume: a link between thrombosis and inflammation? Curr Pharm Des. 2011;17:47–58.PubMedCrossRef
Metadaten
Titel
A new model using platelet indices to predict liver fibrosis in patients with chronic hepatitis B infection
verfasst von
Bahadir Ceylan, MD
Bilgül Mete
Muzaffer Fincanci
Turan Aslan
Yasemin Akkoyunlu
Nail Ozguneş
Onur Colak
Alper Gunduz
Ebubekir Senates
Resat Ozaras
Ayşe İnci
Fehmi Tabak
Publikationsdatum
01.08.2013
Verlag
Springer Vienna
Erschienen in
Wiener klinische Wochenschrift / Ausgabe 15-16/2013
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI
https://doi.org/10.1007/s00508-013-0394-3

Weitere Artikel der Ausgabe 15-16/2013

Wiener klinische Wochenschrift 15-16/2013 Zur Ausgabe